Novo Nordisk A/S Common Stock · Cash & Short-Term Investments

Latest reportedkr 26.96B DKKperiod endingDec 31, 2025

NVO FY Cash & Short-Term Investments · DKK (kr 2.11B → kr 26.96B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

NVO cash & short-term investments history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Cash & Short-Term Investments — Annual fiscal periods (DKK)
Period ending	Cash & Short-Term Investments (DKK)
Dec 31, 2025	26,962,000,000
Dec 31, 2024	26,308,000,000
Dec 31, 2023	30,230,000,000
Dec 31, 2022	23,574,000,000
Dec 31, 2021	17,485,000,000
Dec 31, 2020	12,757,000,000
Dec 31, 2019	15,475,000,000
Dec 31, 2018	15,638,000,000
Dec 31, 2017	18,852,000,000
Dec 31, 2016	20,699,000,000
Dec 31, 2015	20,465,000,000
Dec 31, 2014	15,905,000,000
Dec 31, 2013	14,469,000,000
Dec 31, 2012	16,105,000,000
Dec 31, 2011	17,502,000,000
Dec 31, 2010	16,051,000,000
Dec 31, 2009	12,826,000,000
Dec 31, 2008	10,184,876,800
Dec 31, 2007	7,384,616,000
Dec 31, 2006	5,102,491,800
Dec 31, 2005	5,017,968,080
Dec 31, 2004	3,989,637,870
Dec 31, 2003	3,098,254,800
Dec 31, 2002	1,741,111,740
Dec 31, 2001	3,049,213,650
Dec 31, 2000	1,275,370,800
Dec 31, 1999	1,973,933,670
Dec 31, 1998	798,675,108
Dec 31, 1997	1,122,911,280
Dec 31, 1996	1,572,002,159
Dec 31, 1995	2,999,884,600
Dec 31, 1994	6,684,733,370
Dec 31, 1993	5,706,441,000
Dec 31, 1992	5,818,998,250
Dec 31, 1991	6,035,909,450
Dec 31, 1990	4,338,353,600
Dec 31, 1989	2,947,605,750
Dec 31, 1988	2,520,695,800
Dec 31, 1987	2,047,814,350
Dec 31, 1986	1,994,223,000
Dec 31, 1985	2,105,643,600